Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,895 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Fisetin ameliorates vascular calcification by regulating HNRNPA1-mediated ferroptosis (2025-06-17)
Journal: ANNALS OF VASCULAR SURGERY (2025) IF: 1.6Products Cited: Fetal Bovine Serum -
Fosinopril ameliorates renal injury in diabetic nephropathy by inactivating the SRC/NF-κB pathway (2025-06-18)
Journal: Letters in Drug Design & Discovery (2025) IF: 1.6Products Cited: MEM Non-Essential Amino Acid Solution (NEAA), 100 ×, MEM Medium -
The inhibitory effects of Cucurbitacin B on hypopharyngeal cancer cell malignant behaviors were investigated based on network pharmacology and molecular docking (2025-06-17)
Journal: Letters in Drug Design & Discovery (2025) IF: 1.6Products Cited: Penicillin-Streptomycin Solution, 100 × -
Network pharmacology, molecular docking, and experimental validation to explore dihydromyricetin attenuates LPS-induced acute lung injury by promoting FGFR1 (2025-07-07)
Journal: Letters in Drug Design & Discovery (2025) IF: 1.6Products Cited: BEAS-2B Cells Line, Fetal Bovine Serum -
Andrographolide inhibits microglia inflammation and M1-like macrophage polarization after traumatic brain injury by regulating BRD4 expression (2025-08-19)
Journal: Letters in Drug Design & Discovery (2025) IF: 1.6Products Cited: Penicillin-Streptomycin Solution, 100 ×, MEM Medium -
Uncovering the mechanism of ARRDC3 in non-small cell lung cancer cisplatin resistance and autophagy based on bioinformatics and experimental verification (2025-08-19)
Journal: Letters in Drug Design & Discovery (2025) IF: 1.6Products Cited: Human Bronchial Epithelial Cells -
Network pharmacology and experimental verification reveals the anti-growth and anti-migration roles of allicin in non-small cell lung cancer (2025-08-19)
Journal: Letters in Drug Design & Discovery (2025) IF: 1.6Products Cited: Ham's F-12K Medium, MEM, with NEAA Medium -
Investigation into the mechanism of columbianadin’s inhibition of breast cancer development using network pharmacology and molecular dynamics simulation (2025-10-07)
Journal: Letters in Drug Design & Discovery (2025) IF: 1.6 -
Revealing the neuroprotective mechanism of irisin on stroke based on network pharmacology, molecular docking and experimental validation (2025-10-15)
Journal: Letters in Drug Design & Discovery (2025) IF: 1.6Products Cited: -
Exploring the molecular mechanism of Qilian Fuzheng capsule for treatment of non-small cell lung cancer using network pharmacology, RNA-seq, molecular docking and experimental verification (2025-10-22)
Journal: Letters in Drug Design & Discovery (2025) IF: 1.6
